Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04231409 · ClinicalTrials.gov registry record · NA
Fast-Acting Subperception Study (FAST)
A NA study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT04231409 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 41 participants.
The verdict
NCT04231409, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Study to Demonstrate the Value of Fast-Acting Subperception (FAST) using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain
Interventions
- DEVICE Boston Scientific Spectra WaveWriter SCS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2020-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04231409
The ClinicalTrials.gov registry entry for NCT04231409 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Boston Scientific Spectra WaveWriter SCS System is the first listed.
NCT04231409 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04231409 about?
NCT04231409 is a clinical study titled "Fast-Acting Subperception Study (FAST)". Study to Demonstrate the Value of Fast-Acting Subperception (FAST) using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain
What is the current status of trial NCT04231409?
This trial is currently terminated. It is a NA study. The enrollment target is 41 participants. The study started on 2019-11-26. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT04231409?
The interventions under investigation include: Boston Scientific Spectra WaveWriter SCS System (DEVICE).
Who is sponsoring clinical trial NCT04231409?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.